0.027270 0.015744 0.000000 0.000000 0.031489 0.000000 0.000000 0.000000 0.006926 0.00000 0.00000 0.00000 Saraboji, K. Nordlund, A. Leinartait, L. Oliveberg, M. Logan, D.T. http://mmcif.pdb.org/dictionaries/ascii/mmcif_pdbx.dic 6 90.00 90.00 120.00 36.670 36.670 144.390 C3 H7 N O2 89.093 y ALANINE L-peptide linking C6 H15 N4 O2 1 175.209 y ARGININE L-peptide linking C4 H8 N2 O3 132.118 y ASPARAGINE L-peptide linking C4 H7 N O4 133.103 y ASPARTIC ACID L-peptide linking C3 H7 N O2 S 121.158 y CYSTEINE L-peptide linking C5 H10 N2 O3 146.144 y GLUTAMINE L-peptide linking C5 H9 N O4 147.129 y GLUTAMIC ACID L-peptide linking C2 H5 N O2 75.067 y GLYCINE peptide linking C6 H10 N3 O2 1 156.162 y HISTIDINE L-peptide linking H2 O 18.015 WATER non-polymer C6 H13 N O2 131.173 y ISOLEUCINE L-peptide linking C6 H13 N O2 131.173 y LEUCINE L-peptide linking C6 H15 N2 O2 1 147.195 y LYSINE L-peptide linking C9 H11 N O2 165.189 y PHENYLALANINE L-peptide linking C5 H9 N O2 115.130 y PROLINE L-peptide linking C3 H7 N O3 105.093 y SERINE L-peptide linking C4 H9 N O3 119.119 y THREONINE L-peptide linking C11 H12 N2 O2 204.225 y TRYPTOPHAN L-peptide linking C5 H11 N O2 117.146 y VALINE L-peptide linking Zn 2 65.409 ZINC ION non-polymer US Proc.Natl.Acad.Sci.USA PNASA6 0040 0027-8424 106 9667 9672 10.1073/pnas.0812046106 19497878 Functional features cause misfolding of the ALS-provoking enzyme SOD1. 2009 10.2210/pdb3hff/pdb pdb_00003hff 1.000000 0.000000 0.000000 0.000000 1.000000 0.000000 0.000000 0.000000 1.000000 0.00000 0.00000 0.00000 100 1 CCD 2008-10-22 MAR CCD 165 mm SINGLE WAVELENGTH M x-ray 1 0.9083 1.0 I911-5 MAX II 0.9083 SYNCHROTRON MAX II BEAMLINE I911-5 15636.213 Superoxide dismutase [Cu-Zn] 1.15.1.1 C6A, C111A, F50E, G51E, H63S, H71S, H80S, D83S 1 man polymer 65.409 ZINC ION 5 syn non-polymer 18.015 water 28 nat water CU/ZN SUPEROXIDE DISMUTASE no no ATKAVAVLKGDGPVQGIINFEQKESNGPVKVWGSIKGLTEGLHGFHVHEEEDNTAGCTSAGPSFNPLSRKSGGPKDEERS VGSLGNVTADKDGVADVSIEDSVISLSGDHAIIGRTLVVHEKADDLGKGGNEESTKTGNAGSRLACGVIGIAQ ATKAVAVLKGDGPVQGIINFEQKESNGPVKVWGSIKGLTEGLHGFHVHEEEDNTAGCTSAGPSFNPLSRKSGGPKDEERS VGSLGNVTADKDGVADVSIEDSVISLSGDHAIIGRTLVVHEKADDLGKGGNEESTKTGNAGSRLACGVIGIAQ A polypeptide(L) n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n human sample SOD1 9606 Homo sapiens 562 Escherichia coli BL21/DE3 1 1.79 31.50 VAPOR DIFFUSION, HANGING DROP 8.0 16% PEG 6000, 10% Jeffamine M-600 (pH 7.0), 0.1M Tris-HCl (pH 8.0), 0.1M ZnCl2, VAPOR DIFFUSION, HANGING DROP, temperature 293K 293 diffrn_source software database_2 struct_ref_seq_dif struct_site repository Initial release Advisory Refinement description Version format compliance Data collection Refinement description Database references Derived calculations 1 0 2009-06-16 1 1 2011-07-13 1 2 2017-11-01 1 3 2021-11-10 _diffrn_source.pdbx_synchrotron_site _software.name _database_2.pdbx_DOI _database_2.pdbx_database_accession _struct_ref_seq_dif.details _struct_site.pdbx_auth_asym_id _struct_site.pdbx_auth_comp_id _struct_site.pdbx_auth_seq_id RCSB Y PDBJ 2009-05-11 REL REL ZN ZINC ION HOH water ZN 154 2 ZN ZN 154 A ZN 155 2 ZN ZN 155 A ZN 156 2 ZN ZN 156 A ZN 158 2 ZN ZN 158 A ZN 159 2 ZN ZN 159 A HOH 201 3 HOH HOH 201 A HOH 202 3 HOH HOH 202 A HOH 203 3 HOH HOH 203 A HOH 204 3 HOH HOH 204 A HOH 205 3 HOH HOH 205 A HOH 206 3 HOH HOH 206 A HOH 207 3 HOH HOH 207 A HOH 208 3 HOH HOH 208 A HOH 209 3 HOH HOH 209 A HOH 210 3 HOH HOH 210 A HOH 211 3 HOH HOH 211 A HOH 212 3 HOH HOH 212 A HOH 213 3 HOH HOH 213 A HOH 214 3 HOH HOH 214 A HOH 215 3 HOH HOH 215 A HOH 216 3 HOH HOH 216 A HOH 217 3 HOH HOH 217 A HOH 218 3 HOH HOH 218 A HOH 219 3 HOH HOH 219 A HOH 220 3 HOH HOH 220 A HOH 221 3 HOH HOH 221 A HOH 222 3 HOH HOH 222 A HOH 223 3 HOH HOH 223 A HOH 224 3 HOH HOH 224 A HOH 225 3 HOH HOH 225 A HOH 226 3 HOH HOH 226 A HOH 227 3 HOH HOH 227 A HOH 228 3 HOH HOH 228 A ALA 1 n 1 ALA 1 A THR 2 n 2 THR 2 A LYS 3 n 3 LYS 3 A ALA 4 n 4 ALA 4 A VAL 5 n 5 VAL 5 A ALA 6 n 6 ALA 6 A VAL 7 n 7 VAL 7 A LEU 8 n 8 LEU 8 A LYS 9 n 9 LYS 9 A GLY 10 n 10 GLY 10 A ASP 11 n 11 ASP 11 A GLY 12 n 12 GLY 12 A PRO 13 n 13 PRO 13 A VAL 14 n 14 VAL 14 A GLN 15 n 15 GLN 15 A GLY 16 n 16 GLY 16 A ILE 17 n 17 ILE 17 A ILE 18 n 18 ILE 18 A ASN 19 n 19 ASN 19 A PHE 20 n 20 PHE 20 A GLU 21 n 21 GLU 21 A GLN 22 n 22 GLN 22 A LYS 23 n 23 LYS 23 A GLU 24 n 24 GLU 24 A SER 25 n 25 SER 25 A ASN 26 n 26 ASN 26 A GLY 27 n 27 GLY 27 A PRO 28 n 28 PRO 28 A VAL 29 n 29 VAL 29 A LYS 30 n 30 LYS 30 A VAL 31 n 31 VAL 31 A TRP 32 n 32 TRP 32 A GLY 33 n 33 GLY 33 A SER 34 n 34 SER 34 A ILE 35 n 35 ILE 35 A LYS 36 n 36 LYS 36 A GLY 37 n 37 GLY 37 A LEU 38 n 38 LEU 38 A THR 39 n 39 THR 39 A GLU 40 n 40 GLU 40 A GLY 41 n 41 GLY 41 A LEU 42 n 42 LEU 42 A HIS 43 n 43 HIS 43 A GLY 44 n 44 GLY 44 A PHE 45 n 45 PHE 45 A HIS 46 n 46 HIS 46 A VAL 47 n 47 VAL 47 A HIS 48 n 48 HIS 48 A GLU 49 n 49 GLU 49 A GLU 50 n 50 GLU 50 A n 51 51 A n 52 52 A n 53 53 A n 54 54 A n 55 55 A n 56 56 A n 57 57 A n 58 58 A n 59 59 A n 60 60 A n 61 61 A n 62 62 A n 63 63 A n 64 64 A n 65 65 A n 66 66 A n 67 67 A n 68 68 A n 69 69 A n 70 70 A n 71 71 A n 72 72 A n 73 73 A n 74 74 A n 75 75 A n 76 76 A n 77 77 A n 78 78 A n 79 79 A n 80 80 A VAL 81 n 81 VAL 81 A GLY 82 n 82 GLY 82 A SER 83 n 83 SER 83 A LEU 84 n 84 LEU 84 A GLY 85 n 85 GLY 85 A ASN 86 n 86 ASN 86 A VAL 87 n 87 VAL 87 A THR 88 n 88 THR 88 A ALA 89 n 89 ALA 89 A ASP 90 n 90 ASP 90 A LYS 91 n 91 LYS 91 A ASP 92 n 92 ASP 92 A GLY 93 n 93 GLY 93 A VAL 94 n 94 VAL 94 A ALA 95 n 95 ALA 95 A ASP 96 n 96 ASP 96 A VAL 97 n 97 VAL 97 A SER 98 n 98 SER 98 A ILE 99 n 99 ILE 99 A GLU 100 n 100 GLU 100 A ASP 101 n 101 ASP 101 A SER 102 n 102 SER 102 A VAL 103 n 103 VAL 103 A ILE 104 n 104 ILE 104 A SER 105 n 105 SER 105 A LEU 106 n 106 LEU 106 A SER 107 n 107 SER 107 A GLY 108 n 108 GLY 108 A ASP 109 n 109 ASP 109 A HIS 110 n 110 HIS 110 A ALA 111 n 111 ALA 111 A ILE 112 n 112 ILE 112 A ILE 113 n 113 ILE 113 A GLY 114 n 114 GLY 114 A ARG 115 n 115 ARG 115 A THR 116 n 116 THR 116 A LEU 117 n 117 LEU 117 A VAL 118 n 118 VAL 118 A VAL 119 n 119 VAL 119 A HIS 120 n 120 HIS 120 A GLU 121 n 121 GLU 121 A LYS 122 n 122 LYS 122 A ALA 123 n 123 ALA 123 A ASP 124 n 124 ASP 124 A ASP 125 n 125 ASP 125 A LEU 126 n 126 LEU 126 A GLY 127 n 127 GLY 127 A LYS 128 n 128 LYS 128 A GLY 129 n 129 GLY 129 A GLY 130 n 130 GLY 130 A ASN 131 n 131 ASN 131 A n 132 132 A n 133 133 A n 134 134 A n 135 135 A n 136 136 A n 137 137 A n 138 138 A ASN 139 n 139 ASN 139 A ALA 140 n 140 ALA 140 A GLY 141 n 141 GLY 141 A SER 142 n 142 SER 142 A ARG 143 n 143 ARG 143 A LEU 144 n 144 LEU 144 A ALA 145 n 145 ALA 145 A CYS 146 n 146 CYS 146 A GLY 147 n 147 GLY 147 A VAL 148 n 148 VAL 148 A ILE 149 n 149 ILE 149 A GLY 150 n 150 GLY 150 A ILE 151 n 151 ILE 151 A ALA 152 n 152 ALA 152 A n 153 153 A 2.2575 -0.1098 0.5447 3.2447 -1.4004 5.6545 -0.0025 -0.1628 0.0625 -0.0368 -0.0899 -0.1844 -0.1830 0.2118 0.0925 0.0363 -0.0429 0.0156 0.0721 -0.0026 0.0888 refined 15.1292 -15.9840 10.2232 X-RAY DIFFRACTION A 1 A 152 X-RAY DIFFRACTION 1 author_defined_assembly 1 monomeric software_defined_assembly PISA 2 dimeric 1130 -6 11820 A ALA 1 A N ALA 1 1_555 A ZN 156 D ZN ZN 1_555 A ALA 1 A O ALA 1 1_555 77.7 A ALA 1 A N ALA 1 1_555 A ZN 156 D ZN ZN 1_555 A HOH 206 G O HOH 1_555 87.1 A ALA 1 A O ALA 1 1_555 A ZN 156 D ZN ZN 1_555 A HOH 206 G O HOH 1_555 163.7 A ALA 1 A N ALA 1 1_555 A ZN 156 D ZN ZN 1_555 A HOH 209 G O HOH 1_555 108.8 A ALA 1 A O ALA 1 1_555 A ZN 156 D ZN ZN 1_555 A HOH 209 G O HOH 1_555 94.6 A HOH 206 G O HOH 1_555 A ZN 156 D ZN ZN 1_555 A HOH 209 G O HOH 1_555 95.9 A HIS 46 A ND1 HIS 46 1_555 A ZN 154 B ZN ZN 1_555 A HIS 120 A NE2 HIS 120 1_555 98.8 A HIS 46 A ND1 HIS 46 1_555 A ZN 154 B ZN ZN 1_555 A HOH 211 G O HOH 1_555 95.7 A HIS 120 A NE2 HIS 120 1_555 A ZN 154 B ZN ZN 1_555 A HOH 211 G O HOH 1_555 104.8 A ASP 90 A OD2 ASP 90 1_555 A ZN 155 C ZN ZN 1_555 A HOH 208 G O HOH 1_555 111.9 A ASP 125 A OD2 ASP 125 1_555 A ZN 159 F ZN ZN 1_555 A HOH 219 G O HOH 1_555 114.5 1.0000000000 0.0000000000 0.0000000000 0.0000000000 1.0000000000 0.0000000000 0.0000000000 0.0000000000 1.0000000000 1_555 x,y,z identity operation 0.0000000000 0.0000000000 0.0000000000 -0.5000000000 -0.8660254038 0.0000000000 -0.8660254038 0.5000000000 0.0000000000 0.0000000000 0.0000000000 -1.0000000000 6_555 -x,-x+y,-z+1/3 crystal symmetry operation 0.0000000000 0.0000000000 48.1300000000 A O ALA 89 A O ALA 89 A N GLY 41 A N GLY 41 A N GLY 44 A N GLY 44 A O HIS 120 A O HIS 120 A N LEU 117 A N LEU 117 A O GLY 147 A O GLY 147 A O CYS 146 A O CYS 146 A N LYS 9 A N LYS 9 A N LEU 8 A N LEU 8 A O GLY 16 A O GLY 16 A N ASN 19 A N ASN 19 A O TRP 32 A O TRP 32 A N GLY 33 A N GLY 33 A O VAL 97 A O VAL 97 A O ALA 89 A O ALA 89 A N GLY 41 A N GLY 41 A N GLY 44 A N GLY 44 A O HIS 120 A O HIS 120 A N LEU 117 A N LEU 117 A O GLY 147 A O GLY 147 A O CYS 146 A O CYS 146 A N LYS 9 A N LYS 9 A N VAL 5 A N VAL 5 A O GLY 150 A O GLY 150 1 A CD LYS 122 A CD LYS 122 1 Y 1 A CE LYS 122 A CE LYS 122 1 Y 1 A NZ LYS 122 A NZ LYS 122 1 Y 1 A GLU 51 A GLU 51 1 Y 1 A ASP 52 A ASP 52 1 Y 1 A ASN 53 A ASN 53 1 Y 1 A THR 54 A THR 54 1 Y 1 A ALA 55 A ALA 55 1 Y 1 A GLY 56 A GLY 56 1 Y 1 A CYS 57 A CYS 57 1 Y 1 A THR 58 A THR 58 1 Y 1 A SER 59 A SER 59 1 Y 1 A ALA 60 A ALA 60 1 Y 1 A GLY 61 A GLY 61 1 Y 1 A PRO 62 A PRO 62 1 Y 1 A SER 63 A SER 63 1 Y 1 A PHE 64 A PHE 64 1 Y 1 A ASN 65 A ASN 65 1 Y 1 A PRO 66 A PRO 66 1 Y 1 A LEU 67 A LEU 67 1 Y 1 A SER 68 A SER 68 1 Y 1 A ARG 69 A ARG 69 1 Y 1 A LYS 70 A LYS 70 1 Y 1 A SER 71 A SER 71 1 Y 1 A GLY 72 A GLY 72 1 Y 1 A GLY 73 A GLY 73 1 Y 1 A PRO 74 A PRO 74 1 Y 1 A LYS 75 A LYS 75 1 Y 1 A ASP 76 A ASP 76 1 Y 1 A GLU 77 A GLU 77 1 Y 1 A GLU 78 A GLU 78 1 Y 1 A ARG 79 A ARG 79 1 Y 1 A SER 80 A SER 80 1 Y 1 A GLU 132 A GLU 132 1 Y 1 A GLU 133 A GLU 133 1 Y 1 A SER 134 A SER 134 1 Y 1 A THR 135 A THR 135 1 Y 1 A LYS 136 A LYS 136 1 Y 1 A THR 137 A THR 137 1 Y 1 A GLY 138 A GLY 138 1 Y 1 A GLN 153 A GLN 153 1 Y 1 A A O O HIS HOH 110 224 2.13 1 A HIS 110 -118.07 50.16 23.170 -0.02 -0.01 0.00 -0.02 0.00 0.03 0.937 0.902 HYDROGENS HAVE BEEN ADDED IN THE RIDING POSITIONS 0.28087 0.22363 0.22914 2.20 17.13 559 5250 9.6 93.47 16.876 0.217 RANDOM LIKELY RESIDUAL 1 THROUGHOUT 0 MOLECULAR REPLACEMENT 0.355 0.263 0.80 0.80 1.40 MAXIMUM LIKELIHOOD MASK 2.20 17.13 28 851 5 0 818 0.015 0.021 828 0.001 0.020 529 1.397 1.950 1116 1.743 3.000 1310 6.839 5.000 112 47.527 26.250 32 18.798 15.000 136 21.184 15.000 2 0.089 0.200 131 0.004 0.020 942 0.001 0.020 143 0.624 1.500 556 0.126 1.500 246 1.126 2.000 880 1.698 3.000 272 2.874 4.500 236 0.400 0.306 2.256 32 329 20 82.05 2.2 20.0 3HFF 5811 5811 1.0 1.0 0.059 1 14.35 4.7 93.2 0.49 2.2 2.3 2.17 623 1 3.0 82.7 data collection MAR345 phasing PHASER refinement REFMAC 5.5.0044 data reduction XDS data scaling XDS Monomeric human Cu,Zn Superoxide dismutase without Zn ligands 1 N N 2 N N 2 N N 2 N N 2 N N 2 N N 3 N N The oligomeric state predicted by PISA is a putative dimer. metalc 2.228 A ALA 1 A N ALA 1 1_555 A ZN 156 D ZN ZN 1_555 metalc 2.231 A ALA 1 A O ALA 1 1_555 A ZN 156 D ZN ZN 1_555 metalc 1.982 A HIS 46 A ND1 HIS 46 1_555 A ZN 154 B ZN ZN 1_555 metalc 1.813 A ASP 90 A OD2 ASP 90 1_555 A ZN 155 C ZN ZN 1_555 metalc 2.057 A HIS 110 A NE2 HIS 110 1_555 A ZN 158 E ZN ZN 1_555 metalc 1.954 A HIS 120 A NE2 HIS 120 1_555 A ZN 154 B ZN ZN 1_555 metalc 1.993 A ASP 125 A OD2 ASP 125 1_555 A ZN 159 F ZN ZN 1_555 metalc 2.126 A ZN 154 B ZN ZN 1_555 A HOH 211 G O HOH 1_555 metalc 2.351 A ZN 155 C ZN ZN 1_555 A HOH 208 G O HOH 1_555 metalc 2.151 A ZN 156 D ZN ZN 1_555 A HOH 206 G O HOH 1_555 metalc 2.316 A ZN 156 D ZN ZN 1_555 A HOH 209 G O HOH 1_555 metalc 1.898 A ZN 159 F ZN ZN 1_555 A HOH 219 G O HOH 1_555 OXIDOREDUCTASE OXIDOREDUCTASE, SOD1, MONOMERIC MUTANT, Amyotrophic lateral sclerosis, Antioxidant, Disease mutation, Disulfide bond, Metal-binding, Neurodegeneration, Phosphoprotein SODC_HUMAN UNP 1 2 P00441 ATKAVCVLKGDGPVQGIINFEQKESNGPVKVWGSIKGLTEGLHGFHVHEFGDNTAGCTSAGPHFNPLSRKHGGPKDEERH VGDLGNVTADKDGVADVSIEDSVISLSGDHCIIGRTLVVHEKADDLGKGGNEESTKTGNAGSRLACGVIGIAQ 2 154 3HFF 1 153 P00441 A 1 1 153 1 CYS engineered mutation ALA 6 3HFF A P00441 UNP 7 6 1 PHE engineered mutation GLU 50 3HFF A P00441 UNP 51 50 1 GLY engineered mutation GLU 51 3HFF A P00441 UNP 52 51 1 HIS engineered mutation SER 63 3HFF A P00441 UNP 64 63 1 HIS engineered mutation SER 71 3HFF A P00441 UNP 72 71 1 HIS engineered mutation SER 80 3HFF A P00441 UNP 81 80 1 ASP engineered mutation SER 83 3HFF A P00441 UNP 84 83 1 CYS engineered mutation ALA 111 3HFF A P00441 UNP 112 111 8 6 anti-parallel anti-parallel anti-parallel anti-parallel anti-parallel anti-parallel anti-parallel anti-parallel anti-parallel anti-parallel anti-parallel anti-parallel A GLY 82 A GLY 82 A ALA 89 A ALA 89 A GLY 41 A GLY 41 A VAL 47 A VAL 47 A THR 116 A THR 116 A HIS 120 A HIS 120 A ARG 143 A ARG 143 A VAL 148 A VAL 148 A THR 2 A THR 2 A GLY 10 A GLY 10 A GLN 15 A GLN 15 A GLN 22 A GLN 22 A VAL 29 A VAL 29 A LYS 36 A LYS 36 A ALA 95 A ALA 95 A ASP 101 A ASP 101 A GLY 82 A GLY 82 A ALA 89 A ALA 89 A GLY 41 A GLY 41 A VAL 47 A VAL 47 A THR 116 A THR 116 A HIS 120 A HIS 120 A ARG 143 A ARG 143 A VAL 148 A VAL 148 A THR 2 A THR 2 A GLY 10 A GLY 10 A GLY 150 A GLY 150 A ILE 151 A ILE 151 BINDING SITE FOR RESIDUE ZN A 154 A ZN 154 Software 4 BINDING SITE FOR RESIDUE ZN A 155 A ZN 155 Software 5 BINDING SITE FOR RESIDUE ZN A 156 A ZN 156 Software 4 BINDING SITE FOR RESIDUE ZN A 158 A ZN 158 Software 4 BINDING SITE FOR RESIDUE ZN A 159 A ZN 159 Software 3 A HIS 46 A HIS 46 4 1_555 A HIS 120 A HIS 120 4 1_555 A HOH 211 G HOH 4 1_555 A HOH 212 G HOH 4 1_555 A ASP 90 A ASP 90 5 1_555 A ASP 92 A ASP 92 5 1_555 A HOH 204 G HOH 5 4_545 A HOH 207 G HOH 5 1_555 A HOH 208 G HOH 5 1_555 A ALA 1 A ALA 1 4 1_555 A ASP 96 A ASP 96 4 4_655 A HOH 206 G HOH 4 1_555 A HOH 209 G HOH 4 1_555 A ASP 11 A ASP 11 4 1_565 A HIS 110 A HIS 110 4 1_555 A HOH 220 G HOH 4 1_565 A HOH 222 G HOH 4 1_555 A ASP 125 A ASP 125 3 1_555 A HOH 216 G HOH 3 1_555 A HOH 219 G HOH 3 1_555 152 P 31 2 1